Identification of key enzalutamide-resistance-related genes in castration-resistant prostate cancer and verification of RAD51 functions

Patients with castration-resistant prostate cancer (CRPC) often develop drug resistance after treatment with enzalutamide. The goal of our study was to identify the key genes related to enzalutamide resistance in CRPC and to provide new gene targets for future research on improving the efficacy of e...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Wen, Liu, Li, Cui, Zhongqi, Li, Mingyang, Ni, Jinliang, Huang, Nan, Zhang, Yue, Luo, Jie, Sun, Limei, Sun, Fenyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224628/
https://www.ncbi.nlm.nih.gov/pubmed/37251536
http://dx.doi.org/10.1515/med-2023-0715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224628/
https://www.ncbi.nlm.nih.gov/pubmed/37251536
http://dx.doi.org/10.1515/med-2023-0715

Ejemplares similares